Queenlept

Composition:

Croscarmellose sodium, Microcrystalline cellulose (PH 102), Talc, Colloidal Silicon Dioxide (Aerosil  200), Magnesium Stearate.

Capsule cap composition (Opaque white): Titanium dioxide, Gelatin.

Capsule body composition (Opaque white): Titanium dioxide, Gelatin.

Indications:

Neuropathic pain

QUEENLEPT is indicated for the treatment of peripheral neuropathic pain in adults,

Epilepsy

QUEENLEPT is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalization.

Generalised Anxiety Disorder

QUEENLEPT is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

4.2. Posology and method of administration.

The dose range is 150 to 600 mg per day given in either two or three divided doses.

QUEENLEPT may be taken without food.

Dosages and administration:

Times

Total Pregablin Daily dose

Creatinine

Clearance (CLcr)

(ml/min)

 

Maximum dose

(mg/day)

Starting dose

(mg/day)

 

BID or TID

600

150

≥ 60

BID or TID

300

75

≥ 30 -< 60

Once Daily or BID

150

25-50

≥ 15 -< 30

Once Daily

75

25

< 15

Supplementary dosage following haemodialysis (mg)

Single Dose

100

25

 

  • Presentation:
  • Hard Gelatin Capsules.